Vor Biopharma Inc. (VOR)

Vor Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.05	81.95	31.36	57.71	119.8	48.54
Short-Term Investments	9.99	9.98	105.82	172.54	87.67	-
Cash & Short-Term Investments	60.04	91.93	137.18	230.25	207.47	48.54
Cash Growth	-44.14%	-32.99%	-40.42%	10.98%	327.43%	650.68%
Prepaid Expenses	4.52	4.2	3.15	4.37	4.84	0.47
Other Current Assets	0.3	0.38	0.48	2.34	2.09	0.1
Total Current Assets	64.85	96.51	140.8	236.95	214.4	49.11
Property, Plant & Equipment	39.68	41.59	50.1	57.08	22.52	21.85
Other Long-Term Assets	4.78	4.8	7.23	5.34	5.67	4.96
Total Assets	109.31	142.89	198.13	299.37	242.59	75.91
Accounts Payable	3.73	1.51	0.82	1.77	1.55	2.36
Accrued Expenses	8.69	12.89	10.93	8.08	6.34	6.26
Current Portion of Leases	4.27	4.22	3.83	3.27	1.84	0.86
Other Current Liabilities	0.04	-	-	-	0.43	0.72
Total Current Liabilities	16.73	18.61	15.57	13.12	10.15	10.21
Long-Term Leases	26.52	27.62	31.83	35.64	16.17	17.43
Total Liabilities	43.24	46.23	47.4	48.76	26.33	27.64
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	555.51	553.62	490.87	473.59	346.38	2.16
Retained Earnings	-489.48	-456.99	-340.08	-222.22	-130.12	-61.22
Comprehensive Income & Other	0.02	0.02	-0.08	-0.77	-	-
Total Common Equity	66.07	96.66	150.72	250.61	216.26	-59.07
Shareholders' Equity	66.07	96.66	150.72	250.61	216.26	48.27
Total Liabilities & Equity	109.31	142.89	198.13	299.37	242.59	75.91
Total Debt	30.78	31.83	35.66	38.91	18.01	18.29
Net Cash (Debt)	29.25	60.1	101.52	191.33	189.46	30.25
Net Cash Growth	-59.78%	-40.80%	-46.94%	0.99%	526.38%	367.77%
Net Cash Per Share	0.35	0.87	1.51	4.84	5.67	141.56
Filing Date Shares Outstanding	124.96	124.85	68.17	66.37	37.49	37.13
Total Common Shares Outstanding	124.85	124.78	67.89	66	37.17	0.51
Working Capital	48.12	77.9	125.23	223.83	204.25	38.9
Book Value Per Share	0.53	0.77	2.22	3.80	5.82	-116.94
Tangible Book Value	66.07	96.66	150.72	250.61	216.26	-59.07
Tangible Book Value Per Share	0.53	0.77	2.22	3.80	5.82	-116.94
Machinery	17.98	17.15	17.4	15.64	8.77	5.45
Construction In Progress	0.04	0.04	0.15	1.04	-	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q